ribavirin has been researched along with Breast Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, S; Roh, J; Thomas, AA; Venteicher, B; Way, H | 1 |
| Abd-Rabou, AA; Bharali, DJ; Mousa, SA | 2 |
| Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA | 1 |
| Del Rincon, SV; Dobocan, MC; Emond, A; Huor, B; Miller, WH; Ng, J; Ngan, E; Pettersson, F; Siegel, PM | 1 |
| Broglio, KR; Hahn, KM; Hortobagyi, GN; Kau, SC; Morrow, PKH; Tarrand, JJ; Taylor, SH; Theriault, RL | 1 |
| Benz, CC; Borden, KL; Cocolakis, E; Culjkovic-Kraljacic, B; Dobocan, MC; Flores, LM; Krop, IE; Miller, WH; Pettersson, F; Puckett, R; Retrouvay, H; Retrouvey, H; Rousseau, C; Yau, C | 1 |
| Han, HY; Kohli, E; Vinogradov, SV; Zeman, AD | 1 |
| Look, KY; Singhal, RL; Sledge, GW; Weber, G; Yeh, YA | 1 |
| Weber, G; Yeh, YA | 1 |
| Shen, F; Weber, G | 1 |
| Li, W; Prajda, N; Shen, F; Weber, G; Yang, H | 1 |
| Anderlini, P; Champlin, RE; Ghosh, S; Jacobson, K; Kontoyiannis, D; Luna, M; Raad, I; Rolston, K; Tarrand, J; Ueno, NT; Whimbey, E | 1 |
| Beery, E; Nordenberg, J; Novogrodsky, A; Panet, C; Sidi, Y; Wasserman, L | 1 |
14 other study(ies) available for ribavirin and Breast Neoplasms
| Article | Year |
|---|---|
Synthesis of ribavirin 1,2,3- and 1,2,4-triazolyl analogs with changes at the amide and cytotoxicity in breast cancer cell lines.
Topics: Amides; Antineoplastic Agents; Breast Neoplasms; Female; Humans; MCF-7 Cells; Ribavirin; Structure-Activity Relationship; Triazoles | 2023 |
Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.
Topics: Antineoplastic Agents; Biological Availability; Breast Neoplasms; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Inhibitory Concentration 50; Lipids; MCF-7 Cells; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Nanoparticles; Polyethylene Glycols; Ribavirin | 2018 |
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Head and Neck Neoplasms; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Interferons; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Neoplasms; Polyethylene Glycols; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2019 |
Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis.
Topics: Angiogenesis Inhibitors; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Ribavirin | 2020 |
Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Eukaryotic Initiation Factor-4E; Female; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Ribavirin; Transforming Growth Factor beta | 2015 |
Effects of chronic hepatitis C infection on the treatment of breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Hepatitis C, Chronic; Humans; Interferons; Middle Aged; Neoplasm Staging; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult | 2010 |
Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cells, Cultured; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mammary Glands, Human; Organ Specificity; Prognosis; Ribavirin; RNA, Small Interfering; Up-Regulation | 2011 |
Formulations of biodegradable Nanogel carriers with 5'-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity.
Topics: Adenosine Triphosphate; Animals; Antiviral Agents; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Dideoxynucleotides; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Female; Fluorescent Dyes; Formazans; Humans; Influenza A virus; Inhibitory Concentration 50; Kidney; L-Lactate Dehydrogenase; Luminescent Measurements; Membrane Potentials; Mitochondria; Nanogels; Nanotechnology; Polyethylene Glycols; Polyethyleneimine; Rhodamines; Ribavirin; Sensitivity and Specificity; Tetrazolium Salts; Thymine Nucleotides; Zidovudine | 2007 |
Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells.
Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Division; Depression, Chemical; Down-Regulation; Female; Humans; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Hairless; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Ovary; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Inbred ACI; Ribavirin; Signal Transduction; Tumor Cells, Cultured | 1994 |
Growth inhibitory action of brefeldin A with taxol and tiazofurin in human breast carcinoma cells.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Brefeldin A; Cell Division; Cyclopentanes; Drug Synergism; Humans; Macrolides; Paclitaxel; Ribavirin; Tumor Cells, Cultured | 1995 |
Tamoxifen downregulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Down-Regulation; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Inositol 1,4,5-Trisphosphate; Ribavirin; Signal Transduction; Tamoxifen; Tumor Cells, Cultured | 1998 |
Amplification of signal transduction capacity and down-regulation by drugs.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Differentiation; Cell Division; Colonic Neoplasms; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Genistein; Humans; Inositol Phosphates; Liver Neoplasms, Experimental; Neoplasms; Ovarian Neoplasms; Phosphoric Monoester Hydrolases; Rats; Ribavirin; Signal Transduction; Tamoxifen; Tumor Cells, Cultured | 1999 |
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
Topics: Aerosols; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Breast Neoplasms; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Autologous | 2001 |
Growth inhibition and induction of phenotypic alterations by tiazofurin: differential effects on MCF-7 breast cancer and HBL-100 breast cell lines.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Division; Cell Line; Female; Guanosine Triphosphate; Humans; Milk, Human; Mycophenolic Acid; Ribavirin; Ribonucleosides; Tumor Cells, Cultured | 1989 |